NASDAQ

Dermata Therapeutics, Inc. - Warrant (DRMAW)

♥ 694 Thanks from members

Community market perspectives and discussion for Dermata Therapeutics, Inc. - Warrant (NASDAQ: DRMAW).

No chart available for this instrument.

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Dermata Therapeutics ManagementLeadership: Gerald Proehl (CEO)Holder: Dermata Therapeutics Insider HoldingsHolder: Private Healthcare InvestorsDermata WarrantsDMT310 Topical Treatment#DRMAW#Dermata Therapeutics#biotech warrants#dermatology treatments#NASDAQ DRMAW